Ardent Health, Inc. (ARDT) Guidance & Earnings Results

On 2026-08-04 Ardent Health, Inc. mixed guidance: "FY26 revenue reaffirmed $6,400-$6,700M; Adjusted EBITDA reaffirmed $485-$535M; Net income lowered to $110-$163M from $129-$183M; Adjusted admissions growth 1.5%-2.5%; Capex…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ARDTArdent Health, Inc.Follow ARDT — free

Medical Care Facilities · Healthcare

—

Price chart with a free account

Market cap: 1.7B
P/E TTM: 22.3
Dividend yield: —
52-week: —
Next earnings: 4 Nov, in 11 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
4 Aug 26	Mixed	FY26 revenue reaffirmed $6,400-$6,700M; Adjusted EBITDA reaffirmed $485-$535M; Net income lowered to $110-$163M from $129-$183M; Adjusted admissions growth 1.5%-2.5%; Capex $225-$265M · full year
5 May 26	Reaffirmed	FY 2026 Total Revenue $6,400-$6,700M; Net Income $129-$183M; Adjusted EBITDA $485-$535M; Rent Expense $168M; Diluted EPS $0.90-$1.27; Adjusted Admissions Growth 1.5%-2.5%; Capital Expenditures $225-$265M · full year
4 Mar 26	Mixed	FY26 revenue $6,400-6,700M; FY26 Adj. EBITDA $485-535M; FY26 net income $221-280M; FY26 capex not explicitly guided but implied by D&A $170-175M · full year
12 Nov 25	Lowered	FY2025 adjusted EBITDA guidance revised to $530-555M from $575-615M; revenue guidance reaffirmed at $6,200-6,450M; net income guidance cut to $121-146M from $245-285M; EPS guidance cut to $0.85-1.03 from $1.73-2.01; capex unchanged at $215-235M; adjusted admissions growth unchanged at 2-3%; net patient service revenue per adjusted admission growth unchanged at 2.1-4.4% · full year
5 Aug 25	Reaffirmed	FY2025 revenue $6.2-6.45B; Adjusted EBITDA $575-615M; Capex $215-235M; Net income $245-285M; Diluted EPS $1.73-2.01; Adjusted admissions growth 2.0-3.0%; Net patient service revenue per adjusted admission growth 2.1-4.4% · full year

Ardent Health, Inc. — questions

What guidance did Ardent Health, Inc. give?: On 2026-08-04: "FY26 revenue reaffirmed $6,400-$6,700M; Adjusted EBITDA reaffirmed $485-$535M; Net income lowered to $110-$163M from $129-$183M; Adjusted admissions growth 1.5%-2.5%; Capex $225-$265M"
When does Ardent Health, Inc. report earnings?: Ardent Health, Inc.'s next earnings report is expected on 2026-11-04.

Every figure on this page comes from Ardent Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.